Calabresi PA, Giovannoni G, Hartung HP, Naismith RT, et al. Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial. Mult Scler 2026;32:107-120.
PMID: 41454463